| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | US7875276 Urinary tract tissue graft compositions and methods for producing same |
| 01/25/2011 | US7875275 Use of Bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes |
| 01/25/2011 | US7875273 Treatment of Parkinson's disease and related disorders using postpartum derived cells |
| 01/25/2011 | US7875272 Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
| 01/25/2011 | US7875259 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 01/25/2011 | US7874998 Filtration devices and related methods thereof |
| 01/25/2011 | CA2635963C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 01/25/2011 | CA2545180C Insulin expressing human pancreatic islet cell line capable of reversibly proliferating and use thereof |
| 01/25/2011 | CA2495743C Fusion proteins and methods of producing same |
| 01/25/2011 | CA2480684C Host cells having improved cell survival properties and methods to generate such cells |
| 01/25/2011 | CA2384425C Methods and compositions for delivery of pharmaceutical agents |
| 01/25/2011 | CA2378519C Human cytokine receptor |
| 01/25/2011 | CA2363851C Use of collagenase in the preparation of neural stem cell cultures |
| 01/25/2011 | CA2355768C Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 01/25/2011 | CA2344467C Ucp4 |
| 01/25/2011 | CA2338186C Tumor necrosis factor-gamma |
| 01/25/2011 | CA2321089C Human homolog of the drosophila protein "fused" |
| 01/25/2011 | CA2292378C A method of inhibiting cancer cell growth using a vector expressing prb2/p130 |
| 01/25/2011 | CA2281858C A method for making infectious, propagation defective tr339 virus particles and helper cells therefor |
| 01/25/2011 | CA2236378C Recombinant sendai virus |
| 01/25/2011 | CA2174098C Method of inducing and maintaining neuronal cells |
| 01/20/2011 | WO2011009106A2 Methods and compositions for in vitro and in vivo chondrogenesis |
| 01/20/2011 | WO2011009064A1 Methods of controlling cell proliferation |
| 01/20/2011 | WO2011009054A1 Composition and method for maintenance, differentiation, and proliferation of stem cells |
| 01/20/2011 | WO2011008986A2 A method applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves |
| 01/20/2011 | WO2011008867A1 Cell-free synthesis of active reprogramming transcription factors |
| 01/20/2011 | WO2011008863A2 Stereoisomer peptides and their polymer conjugates for hiv disease |
| 01/20/2011 | WO2011008695A2 Materials and methods for flushing and cold/cryo preserving organs, tissues, and cells |
| 01/20/2011 | WO2011008541A2 Molecular markers and assay methods for characterizing cells |
| 01/20/2011 | WO2011008277A2 Hematopoietic stromal progenitor cells and uses thereof |
| 01/20/2011 | WO2011007900A1 Pluripotent stem cell that can be isolated from body tissue |
| 01/20/2011 | WO2011007880A1 Gene capable of regulating number of primary panicle branches and use thereof |
| 01/20/2011 | WO2011007859A1 Dna fragment and pharmaceutical composition |
| 01/20/2011 | WO2011007853A1 Monoclonal antibody for cancer-specific isoform |
| 01/20/2011 | WO2011007847A1 Method for induction of differentiation of pluripotent stem cells into nerve cells |
| 01/20/2011 | WO2011007348A2 Method for using directing cells for specific stem/progenitor cell activation and differentiation |
| 01/20/2011 | WO2011007176A1 Cells, compositions and methods |
| 01/20/2011 | WO2011007110A1 Methods for establishing symbioses |
| 01/20/2011 | WO2011007049A1 Use of animal cells for screening probiotic bacteria strains |
| 01/20/2011 | WO2011006205A1 Method of producing progenitor cells from differentiated cells |
| 01/20/2011 | WO2010138873A8 Long term expansion of human hematopoietic stem cells |
| 01/20/2011 | WO2010080962A3 Heat shock protein deficiencies as model systems for brain pathology and cancer |
| 01/20/2011 | WO2003034984A9 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 01/20/2011 | US20110016589 Methods and compositions for increasing plant transformation efficiency |
| 01/20/2011 | US20110016588 Transgenic plants expressing cytokinin biosynthetic genes and methods of use therefor |
| 01/20/2011 | US20110016587 Promoter, promoter control elements, and combinations, and uses thereof |
| 01/20/2011 | US20110016586 Transgenic plants comprising as transgene a class i tcp or clavata 1 (clv1) or cah3 polypeptide having increased seed yield and a method for making the same |
| 01/20/2011 | US20110016585 Novel delta9-elongase for production of polyunsaturated fatty acid-enriched oils |
| 01/20/2011 | US20110016582 Biosynthetic Engineering of Glucosinolates |
| 01/20/2011 | US20110016581 Delta-8 desaturases and their use in making polyunsaturated fatty acids |
| 01/20/2011 | US20110016580 Cell Division and Proliferation Preferred Regulatory Elements and Uses Thereof |
| 01/20/2011 | US20110016579 Gene of transporter selective to mugineic acid-iron complex |
| 01/20/2011 | US20110016568 Soybean variety a1015657 |
| 01/20/2011 | US20110016567 Soybean variety a1015862 |
| 01/20/2011 | US20110016565 Soybean variety a1015645 |
| 01/20/2011 | US20110016564 Soybean variety a1015646 |
| 01/20/2011 | US20110016563 Soybean variety a1015632 |
| 01/20/2011 | US20110016562 Soybean variety a1015631 |
| 01/20/2011 | US20110016560 Soybean variety a1016184 |
| 01/20/2011 | US20110016559 Soybean variety a1016190 |
| 01/20/2011 | US20110016558 Soybean variety a1016131 |
| 01/20/2011 | US20110016556 Soybean variety a1016495 |
| 01/20/2011 | US20110016555 Soybean variety a1016115 |
| 01/20/2011 | US20110016554 Soybean variety a1016167 |
| 01/20/2011 | US20110016553 Soybean variety a1016511 |
| 01/20/2011 | US20110016552 Soybean variety a1016082 |
| 01/20/2011 | US20110016551 Inbred broccoli line brm50-3906 |
| 01/20/2011 | US20110016550 Woody plants having improved growth characteristics and method for making the same using transcription factors |
| 01/20/2011 | US20110016548 Control of endogenous dnmt1 gene expression by exogenous binary regulatory systems |
| 01/20/2011 | US20110016547 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 01/20/2011 | US20110016546 Porcine genome editing with zinc finger nucleases |
| 01/20/2011 | US20110016545 Xylanases, Nucleic Acids Encoding Them and Methods For Making and Using Them |
| 01/20/2011 | US20110016543 Genomic editing of genes involved in inflammation |
| 01/20/2011 | US20110016542 Canine genome editing with zinc finger nucleases |
| 01/20/2011 | US20110016541 Genome editing of sensory-related genes in animals |
| 01/20/2011 | US20110016540 Genome editing of genes associated with trinucleotide repeat expansion disorders in animals |
| 01/20/2011 | US20110016539 Genome editing of neurotransmission-related genes in animals |
| 01/20/2011 | US20110016537 Cellular model of tauopathies for lead identification and drug discovery |
| 01/20/2011 | US20110015415 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
| 01/20/2011 | US20110015370 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/20/2011 | US20110015262 Systems and methods for treating human inflammatory and proliferative diseases, with a combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibition |
| 01/20/2011 | US20110015250 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE |
| 01/20/2011 | US20110015249 Methods and compositions for treatment of cancer and other angiogenesis-related diseases |
| 01/20/2011 | US20110015239 Inhibitors of calcium-activated chloride channels |
| 01/20/2011 | US20110015232 Pyrrolydine Derivatives as IAP Inhibitors |
| 01/20/2011 | US20110015219 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof |
| 01/20/2011 | US20110015201 Hedgehog pathway antagonists and methods of use |
| 01/20/2011 | US20110015169 Methods for in vitro maturation of ovarian follicles |
| 01/20/2011 | US20110015168 Methods for increasing levels of human fetal hemoglobin |
| 01/20/2011 | US20110015167 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 01/20/2011 | US20110015138 Inhibition of inflammation using antagonists of muc1 |
| 01/20/2011 | US20110015133 Pax2 and pax8 as tumour targets for immunologic and molecular treatment strategies |
| 01/20/2011 | US20110015127 Targeting complement factor h for treatment of diseases |
| 01/20/2011 | US20110015126 Compositions and Methods For Inducing Apoptosis In Tumor Cells |
| 01/20/2011 | US20110015122 Hepatitis b virus-binding polypeptides and methods of use thereof |
| 01/20/2011 | US20110015093 High throughput methods for functionally determining rna interference efficiency |
| 01/20/2011 | US20110015090 Markers of Acute Myeloid Leukemia Stem Cells |
| 01/20/2011 | US20110014707 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 01/20/2011 | US20110014706 Arabidopsis thaliana Genome Sequence and Uses Thereof |